EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Shigella IpaH9.8 limits GBP1-dependent LPS release from intracytosolic bacteria to suppress caspase-4 activation

Lisa Goers iD, Kyungsub Kim, Teagan C Stedman iD, Patrick J Canning, Xiangyu Mou, Nadja Heinz Ernst, Jörn Coers iD, Cammie F Lesser iD

Proceedings of the National Academy of Sciences · 11.04.2023 · 120 (15)

DOI: 10.1073/pnas.2218469120 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 04.04.2023. Verfasst von Lisa Goers und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Bacterial Pathogenesis, Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, MA 02115. Hauptthemen laut MEDLINE: Lipopolysaccharides, Shigella. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, HHS | NIH | NIAID | Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, Division of Intramural Research, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pyroptosis is an inflammatory form of cell death induced upon recognition of invading microbes. During an infection, pyroptosis is enhanced in interferon-gamma-exposed cells via the actions of members of the guanylate-binding protein (GBP) family. GBPs promote caspase-4 (CASP4) activation by enhancing its interactions with lipopolysaccharide (LPS), a component of the outer envelope of Gram-negative bacteria. Once activated, CASP4 promotes the formation of noncanonical inflammasomes, signaling platforms that mediate pyroptosis. To establish an infection, intracellular bacterial pathogens, like Shigella species, inhibit pyroptosis. The pathogenesis of Shigella is dependent on its type III secretion system, which injects ~30 effector proteins into host cells. Upon entry into host cells, Shigella are encapsulated by GBP1, followed by GBP2, GBP3, GBP4, and in some cases, CASP4. It has been proposed that the recruitment of CASP4 to bacteria leads to its activation. Here, we demonstrate that two Shigella effectors, OspC3 and IpaH9.8, cooperate to inhibit CASP4-mediated pyroptosis. We show that in the absence of OspC3, an inhibitor of CASP4, IpaH9.8 inhibits pyroptosis via its known degradation of GBPs. We find that, while some LPS is present within the host cell cytosol of epithelial cells infected with wild-type Shigella, in the absence of IpaH9.8, increased amounts are shed in a GBP1-dependent manner. Furthermore, we find that additional IpaH9.8 targets, likely GBPs, promote CASP4 activation, even in the absence of GBP1. These observations suggest that by boosting LPS release, GBP1 provides CASP4-enhanced access to cytosolic LPS, thus promoting host cell death via pyroptosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LipopolysaccharidesShigellaBacteriaGTP-Binding ProteinsInflammasomesPyroptosisCaspases, Initiator

Stichwörter der Autor:innen

GBP1LPScaspase-4inflammasome

Substanzen

GTP-Binding ProteinsInflammasomesLipopolysaccharidesCaspases, Initiator

Autor:innen und Institutionen

  • Center for Bacterial Pathogenesis, Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, MA 02115.
  • Department of Microbiology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115.
  • Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, NC 27110.
  • Department of Immunology, Duke University Medical Center, Durham, NC 27110.
  • Broad Institute of Massachusetts General Hospital and Harvard, Cambridge, MA 02142.
  • Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02139.

ORCID-Profile: Lisa Goers, Teagan C Stedman, Jörn Coers, Cammie F Lesser

Förderung

  • NIAID NIH HHS
  • HHS | NIH | NIAID | Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases
  • Division of Intramural Research, National Institute of Allergy and Infectious Diseases

Zitieren

APA

Goers, L., Kim, K., Stedman, T. C., Canning, P. J., Mou, X., Ernst, N. H., Coers, J., & Lesser, C. F. (2023). Shigella IpaH9.8 limits GBP1-dependent LPS release from intracytosolic bacteria to suppress caspase-4 activation. Proceedings of the National Academy of Sciences, 120(15). https://doi.org/10.1073/pnas.2218469120

Vancouver

Goers L, Kim K, Stedman TC, Canning PJ, Mou X, Ernst NH, et al. Shigella IpaH9.8 limits GBP1-dependent LPS release from intracytosolic bacteria to suppress caspase-4 activation. Proceedings of the National Academy of Sciences. 2023;120(15). doi:10.1073/pnas.2218469120

BibTeX
@article{Goers2023,
  author = {Goers, Lisa and Kim, Kyungsub and Stedman, Teagan C and Canning, Patrick J and Mou, Xiangyu and Ernst, Nadja Heinz and Coers, Jörn and Lesser, Cammie F},
  title = {Shigella IpaH9.8 limits GBP1-dependent LPS release from intracytosolic bacteria to suppress caspase-4 activation},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2023},
  volume = {120},
  number = {15},
  doi = {10.1073/pnas.2218469120}
}
Kostenlos starten →